RFI for Clinician Advisory Services
Closed State & local contract opportunity Posted
- Solicitation number
- S-44000-00015479
- State
- Oregon
- Responses due
Opportunity facts
- Jurisdiction
- NIGP codes
- UNSPSC codes
- Points of contact
-
- Procurement Department dfr.procurement@dcbs.oregon.gov (503) 428-4752
- DCBS Stockroom dcbs.stockroom@dcbs.oregon.gov (503) 947-7954
- Daniel Robinson daniel.k.robinson@dcbs.oregon.gov (503) 302-9747
Opportunity details come from oregonbuys.gov. Updated .
About this opportunity
The State of Oregon, Department of Consumer and Business Services, Division of Financial Regulation, has issued a Request for Information (RFI) for Clinician Advisory Services to support the Oregon Prescription Drug Affordability Board. The RFI seeks vendors capable of providing comprehensive clinical advisory consultation, with specific focus on supporting drug affordability reviews. Key deliverables include developing clinical profiles for drugs under review, confirming drug specifications, providing therapeutic alternative information, and generating supporting clinical documentation. Minimum qualifications require at least one team member to hold a Doctor of Pharmacy (PharmD) degree actively used in a professional capacity. Respondents must demonstrate experience consulting for public entities, conducting clinical drug reviews, and describe their process for completing outlined objectives. The RFI requires electronic submission by January 30, 2026, at 2:00 PM Pacific Time to DCBS.Opportunity@oregon.gov, with preliminary questions and clarifications due by January 14, 2026, and answers to be provided by January 21, 2026.
The RFI does not specify set-aside designations or restrictions on responding organizations, nor does it indicate incumbent vendors or existing technology infrastructure requirements. The document explicitly states this is an informational gathering phase and will not result in immediate contract awards or binding agreements. All costs associated with preparing and submitting responses will be the responsibility of the submitter and will not be reimbursed by the State of Oregon. Respondents must complete a Respondent Summary Page (Attachment A) and potentially file a Disclosure Exemption Affidavit (Attachment B) to claim confidentiality for proprietary information. While no specific award value or budget range is provided, the RFI suggests this information-gathering process may inform the development of a subsequent formal solicitation for clinician advisory services for the Oregon Prescription Drug Affordability Board.
Opportunity text
This request for information (RFI) is issued by the State of Oregon, Department of Consumer and Business Services, Division of Financial Regulation (Agency) to seek Clinician Advisory Services for the Oregon Prescription Drug Affordability Board to consider.
Files
| File | Type | Posted |
|---|---|---|
| Att. A_RFI_S-44000-00015479_Respondent Summary.docx | DOCX document | |
| RFI S-44000-00015479_Clinician Advisory Services.pdf | ||
| Att. B_RFI_S-44000-00015479_Disclosure Exemption Affidavit.docx | DOCX document |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Similar opportunities
- Ask GovTribe AI about this opportunity